ATF5 antibody (C-Term)
Quick Overview for ATF5 antibody (C-Term) (ABIN950552)
Target
See all ATF5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 187-216, C-Term
-
Specificity
- This antibody reacts to ATF5.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 187-216 amino acids from the C-terminal region of human ATF5
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ATF5 (Activating Transcription Factor 5 (ATF5))
-
Alternative Name
- ATF5
-
Background
- Transcriptional activator which binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters and blocks the differentiation of neuroprogenitor cells into neurons. Its transcriptional activity is enhanced by CCND3 and slightly inhibited by CDK4.Synonyms: ATF-5, ATFX, Activating transcription factor 5, Cyclic AMP-dependent transcription factor ATF-5, Transcription factor ATFx, cAMP-dependent transcription factor ATF-5
-
Gene ID
- 22809
-
NCBI Accession
- NP_001180575
-
Pathways
- Myometrial Relaxation and Contraction
Target
-